2022
DOI: 10.1039/d2bm00472k
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial mechanisms of biomaterials: from macro to nano

Abstract: Overcoming the global concern of antibiotic resistance is one of the biggest challenge faced by scientists today and the key to tackle this issue of emerging infectious diseases is the...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
34
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 36 publications
(37 citation statements)
references
References 260 publications
3
34
0
Order By: Relevance
“…As the design of biomaterials in combination with AMPs has shown excellent potential for in vivo applications, this review focused on evaluating biomaterial-based AMP therapies. [138] With the development of advanced biomaterials (nanoparticles, chitosan, porous materials, and polymers) coupled with novel AMPs designed with promising bactericidal properties, AMP-based biomaterial therapies offer significant advantages for the treatment of bacterial infections. [139] Compared with single peptides, AMPs that incorporate biomaterials achieve slow release, provide effective local concentrations, reduce off-target effects and toxicity, improve the stability and activity of the AMPs, and modulate the efficacy of the local microenvironment.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As the design of biomaterials in combination with AMPs has shown excellent potential for in vivo applications, this review focused on evaluating biomaterial-based AMP therapies. [138] With the development of advanced biomaterials (nanoparticles, chitosan, porous materials, and polymers) coupled with novel AMPs designed with promising bactericidal properties, AMP-based biomaterial therapies offer significant advantages for the treatment of bacterial infections. [139] Compared with single peptides, AMPs that incorporate biomaterials achieve slow release, provide effective local concentrations, reduce off-target effects and toxicity, improve the stability and activity of the AMPs, and modulate the efficacy of the local microenvironment.…”
Section: Discussionmentioning
confidence: 99%
“…As the design of biomaterials in combination with AMPs has shown excellent potential for in vivo applications, this review focused on evaluating biomaterial‐based AMP therapies. [ 138 ]…”
Section: Discussionmentioning
confidence: 99%
“…The high affinity of GN-based materials towards membrane proteoglycans leads to membrane damage. Another mechanism of action is the further internal leakage of GN-based materials into cells which can lead to the inhibition of DNA/RNA replication [ 8 ]. Therefore, it is proposed that the mode of action of GN towards bacteria is by physical means as well as by chemical means [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…These are materials with one or more dimensions in the nanoscale range of 1–100 nm due to which they exhibit unique physiochemical properties compared to bulk materials. Nanoparticles have a high surface-to-volume ratio, which contributes to their chemical reactivity and biological activities, and their small size allows them to easily penetrate microbial cell membranes and the biofilm EPS layer, resulting in irreversible cell damage and, eventually, cell death. Therefore, nanocoating materials are used to modify the surface properties of intrinsic medical devices/implants in order to prevent biofilm infections. To target the first step of biofilm formation, namely, the attachment of planktonic bacteria to implant surfaces, one approach is to make the surface resistant to biofilm formation and to obstruct the protein adsorption process.…”
Section: Introductionmentioning
confidence: 99%